BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1822027)

  • 21. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
    Thongboonkerd V; Semangoen T; Chutipongtanate S
    Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibition of calcium oxalate monohydrate crystal growth by maleic acid copolymers.
    Bouropoulos K; Bouropoulos N; Melekos M; Koutsoukos PG; Chitanu GC; Anghelescu-Dogaru AG; Carpov AA
    J Urol; 1998 May; 159(5):1755-61. PubMed ID: 9554407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kinetics of dissolution of calcium oxalate hydrates. II. The dihydrate.
    Tomazic B; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):97-101. PubMed ID: 7410038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uric acid as inducer of calcium oxalate crystal development.
    Grases F; Sanchis P; Isern B; Perelló J; Costa-Bauzá A
    Scand J Urol Nephrol; 2007; 41(1):26-31. PubMed ID: 17366099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin.
    Hunter GK; Grohe B; Jeffrey S; O'Young J; Sørensen ES; Goldberg HA
    Cells Tissues Organs; 2009; 189(1-4):44-50. PubMed ID: 18703867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
    Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
    Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of calcium oxalate monohydrate crystals influenced by Costus igneus aqueous extract.
    Kesavan M; Kaliaperumal R; Tamilmani E; Shanmugam K
    Scand J Urol Nephrol; 2012 Aug; 46(4):290-7. PubMed ID: 22545945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How does bovine serum albumin prevent the formation of kidney stone? A kinetics study.
    Liu J; Jiang H; Liu XY
    J Phys Chem B; 2006 May; 110(18):9085-9. PubMed ID: 16671718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.
    Koutsoukos PG; Sheehan ME; Nancollas GH
    Invest Urol; 1981 Mar; 18(5):358-63. PubMed ID: 7203960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of vinyl sulfonic acid homopolymer in calcium oxalate crystallization.
    Kirboğa S; Oner M
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):357-62. PubMed ID: 20400275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of crystallization of calcium oxalate dihydrate in micellar solutions of anionic surfactants.
    Furedi-Milhofer H; Tunik L; Filipovic-Vincekovic N; Skrtic D; Babic-Ivancic V; Garti N
    Scanning Microsc; 1995; 9(4):1061-69; discussion 1069-70. PubMed ID: 8819887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biogenic synthesis of calcium oxalate crystal by reaction of calcium ions with spinach lixivium.
    Li SK; Xie AJ; Shen YH; Yu XR; Hu G
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):229-36. PubMed ID: 20399625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction between nephrocalcin and Tamm-Horsfall proteins with calcium oxalate dihydrate.
    Deganello S
    Scanning Microsc; 1993 Sep; 7(3):1111-8. PubMed ID: 8146610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of hydrodynamic and thermodynamic factors and the addition of citric acid on the precipitation of calcium oxalate dihydrate.
    Šter A; Šafranko S; Bilić K; Marković B; Kralj D
    Urolithiasis; 2018 Jun; 46(3):243-256. PubMed ID: 28646305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of surface active molecules on the crystallization of biominerals in solution.
    Sikirić MD; Füredi-Milhofer H
    Adv Colloid Interface Sci; 2006 Dec; 128-130():135-58. PubMed ID: 17254533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of the phase transformation of calcium oxalate trihydrate-monohydrate.
    Tomazic BB; Nancollas GH
    Invest Urol; 1979 Mar; 16(5):329-35. PubMed ID: 429126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
    PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium oxalate crystal growth in human urinary stones.
    Kim KM; Johnson FB
    Scan Electron Microsc; 1981; (Pt 3):147-54. PubMed ID: 7330575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.